CNXC vs DXCM · rev $4.96B vs P/E 63, rev $2.50B
Concentrix Corporation (CNXC) versus DexCom Inc (DXCM) — a side-by-side from cached financials, not a winner call.
Concentrix Corporation (CNXC) is a information technology services company listed on US.
DexCom Inc (DXCM) is a medical devices company listed on US.
Latest reported CNXC revenue for 2026-05-31 was $4.96B. Net income was $76.9M. Revenue was up 98.5% from 2026-02-28 to 2026-05-31. CNXC currently screens at market cap $1.70B.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
CNXC currently screens at market cap $1.70B. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Not investment advice. Open the CNXC and DXCM stock pages for the full models.
Not investment advice.